HI
BHVN

Harbour Investments’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Harbour Investments’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-45
Closed -$7K – 3185
2022
Q3 		$7K Hold
45
– – ﹤0.01% 2091
2022
Q2 		$7K Buy
+45
New +$5.75K ﹤0.01% 2091
2021
Q4 		$10K Buy
+73
New +$9.28K ﹤0.01% 1954
2021
Q3 		– Sell
-8,004
Closed -$777K – 4171
2021
Q2 		$777K Sell
8,004
-24
-0.3% -$1.95K 0.02% 515
2021
Q1 		$549K Buy
+8,028
New +$649K 0.02% 581

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return

Harbour Investments's BHVN Position: Q4 2022 in Review

Harbour Investments sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 45 shares — an estimated $7K sold.

Harbour Investments first reported a position in BHVN in Q1 2021 and held it in 5 quarters. The position peaked at $777K in Q2 2021. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • Harbour Investments reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • Harbour Investments sold 45 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $7K.
  • Harbour Investments first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q1 2021 and held it in 5 quarters.
  • Harbour Investments's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $777K in Q2 2021.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on Harbour Investments's 13F filing for Q4 2022, filed 16 Feb 2023.